Pharmacological Management of Chronic Obstructive Lung Disease (COPD). Evidence from a Real-World Perspective

Pharmacological Management of Chronic Obstructive Lung Disease (COPD). Evidence from a Real-World Perspective - Part 2

Published:2019-06-20 Issue:10 Volume:26 Page:1734-1745
ISSN:0929-8673
Container-title:Current Medicinal Chemistry
language:en
Short-container-title:CMC

Author:

Kisialiou Aliaksei¹,Prinzi Giulia¹,Lamonaca Palma¹,Cardaci Vittorio²,Tomino Carlo³,Fini Massimo³,Bonassi Stefano¹,Russo Patrizia¹

Affiliation:

1. Unit of Clinical and Molecular Epidemiology, IRCCS San Raffaele Pisana, Via di Valcannuta, 247, I-00166 Rome, Italy

2. Unit of Pulmonary Rehabilitation, IRCCS San Raffaele Pisana, Via della Pisana, 235, 00163 Rome, Italy

3. Scientific Direction, IRCCS San Raffaele Pisana Via di Valcannuta, 247, I-00166 Rome, Italy

Abstract

Background: We report a comprehensive overview of current COPD therapies from a real-world experience. Objective: Critically review the opportunities and the challenges occurring in the real-world treatment of COPD. Methods: This is a review that also report results from COPD patients treated with standardized therapy including pulmonary rehabilitation (Real World Data – RWD). Conclusion: Comprehensive assessment of COPD management requires strategies able to evaluate efficacy and usefulness in a real-world population, that take into account the interaction between experience and academic training, research, adherence to guidelines and judgments in order to plan the appropriate and optimum use of available strategies.

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology,Molecular Medicine,Drug Discovery,Biochemistry,Organic Chemistry

Reference32 articles.

1. Available at:[Accessed: June 9, 2017]

2. Barnes PJ. Cellular and molecular mechanisms of chronic obstructive pulmonary disease.

3. Postma DS, Bush A, van den Berge M. Risk factors and early origins of chronic obstructive pulmonary disease.

4. Castaldi PJ, Cho MH, San José Estépar R, McDonald ML, Laird N, Beaty TH, Washko G, Crapo JD, Silverman EK. Genome-wide association identifies regulatory Loci associated with distinct local histogram emphysema patterns.

5. Schamberger AC, Mise N, Meiners S, Eickelberg O. Epigenetic mechanisms in COPD: Implications for pathogenesis and drug discovery.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Targeting of MMP-12 for the Treatment of Chronic Obstructive Pulmonary Disease;Journal of Medicinal Chemistry;2020-10-27

2. Revefenacin for the treatment of chronic obstructive pulmonary disease;Expert Review of Clinical Pharmacology;2019-03-22